Upsher-Smith Laboratories LLC, a subsidiary of major Japanese generics company Sawai Pharmaceutical Co. Ltd., has snapped up US and select territory rights to two migraine assets from India's Dr. Reddy's Laboratories Ltd. for over $110m, bolstering its portfolio in the specialty segment.
The two products, Zembrace Symtouch (sumatriptan injection) 3mg and Tosymra (sumatriptan nasal spray) 10mg, which are part of Dr Reddy’s...





![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
